Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Metcalf

Showing results (401-410 of 413) with videos related to

Pageof 42
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2019
Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signalingXiaozheng Zhang, Yinghua Peng, Peter M Grace, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2000
Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130S E Nicholson, D De Souza, L J Fabri, et al.
American Journal of Respiratory and Critical Care Medicine|December 5, 2023
Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung DiseaseDavid N O'Dwyer, John S Kim, Shwu-Fan Ma, et al.
The European Respiratory Journal|October 13, 2022
In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomesRishi Chanderraj, Jennifer M Baker, Stephen G Kay, et al.
Current Biology : CB|June 9, 1999
Suckling defect in mice lacking the soluble haemopoietin receptor NR6W S Alexander, S Rakar, L Robb, et al.
Cell|September 18, 1999
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokineW S Alexander, R Starr, J E Fenner, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2004
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, Zhao Zhao, Eugene Lin, et al.
Assistive Technology : the Official Journal of RESNA|December 24, 2021
A review of innovation strategies and processes to improve access to AT: Looking ahead to open innovation ecosystemsCatherine Holloway, Dafne Zuleima Morgado Ramirez, Tigmanshu Bhatnagar, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradationJ G Zhang, A Farley, S E Nicholson, et al.
Journal of Leukocyte Biology|October 26, 1999
Suppressors of cytokine signaling (SOCS): negative regulators of signal transductionW S Alexander, R Starr, D Metcalf, et al.
Pageof 42

Showing results (401-410 of 413) with videos related to

Sort By:
Pageof 42
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2019
Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signalingXiaozheng Zhang, Yinghua Peng, Peter M Grace, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2000
Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130S E Nicholson, D De Souza, L J Fabri, et al.
American Journal of Respiratory and Critical Care Medicine|December 5, 2023
Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung DiseaseDavid N O'Dwyer, John S Kim, Shwu-Fan Ma, et al.
The European Respiratory Journal|October 13, 2022
In critically ill patients, anti-anaerobic antibiotics increase risk of adverse clinical outcomesRishi Chanderraj, Jennifer M Baker, Stephen G Kay, et al.
Current Biology : CB|June 9, 1999
Suckling defect in mice lacking the soluble haemopoietin receptor NR6W S Alexander, S Rakar, L Robb, et al.
Cell|September 18, 1999
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokineW S Alexander, R Starr, J E Fenner, et al.
Clinical Immunology (Orlando, Fla.)|October 28, 2004
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases)Jan Storek, Zhao Zhao, Eugene Lin, et al.
Assistive Technology : the Official Journal of RESNA|December 24, 2021
A review of innovation strategies and processes to improve access to AT: Looking ahead to open innovation ecosystemsCatherine Holloway, Dafne Zuleima Morgado Ramirez, Tigmanshu Bhatnagar, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradationJ G Zhang, A Farley, S E Nicholson, et al.
Journal of Leukocyte Biology|October 26, 1999
Suppressors of cytokine signaling (SOCS): negative regulators of signal transductionW S Alexander, R Starr, D Metcalf, et al.
Pageof 42